ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2026
Developing multicomponent chronotherapeutic interventions for emerging adults with delayed sleep timing.
Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From shifting the clock to sustaining alignment: toward precision chronotherapy for emerging adults with delayed sleep timing.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Emerging adulthood (ages 18-25) is the developmental peak for delayed sleep and circadian timing and a period of risk for psychopathology. The current study compared two chronotherapeutic interventions targeting delayed sleep timing in emerging adults with no-to-moderate depression. Study 1 (N = 21, ages 18-22, 43% women) was a 2-week morning bright light therapy intervention. Study 2 (N = 15, ages 18-25, 86% women) supplemented 2 weeks of morning bright light therapy with a personalized sleep-wake timing advance and blue-light blocking glasses for 2 h prior to bedtime. After 2 weeks, circadian phase (B = 0.1; SE = 0.1; p = 0.46) and depression symptoms (B = -0.2; SE = 0.1; p = 0.05) did not significantly change in Study 1. In contrast, circadian phase advanced by ~35 min (B = -0.4; SE = 0.2; p = 0.03) and depression symptoms decreased (B = -1.2; SE = 0.3; p < 0.001) in Study 2. Future work in larger, randomized controlled trials with rigorous adherence monitoring is needed to confirm the effectiveness of these interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.